Earnings Scorecard & Analyst Reports for Kamada (NASDAQ:KMDA)

Earnings results for Kamada (NASDAQ:KMDA)

Kamada Ltd. is expected* to report earnings on 05/12/2021 before market open. The report will be for the fiscal Quarter ending Mar 2021. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.05. The reported EPS for the same quarter last year was $0.12.

Kamada last announced its earnings data on February 10th, 2021. The biotechnology company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.03. The firm earned $31.54 million during the quarter, compared to the consensus estimate of $33.17 million. Kamada has generated $0.55 earnings per share over the last year and currently has a price-to-earnings ratio of 12.5. Kamada has confirmed that its next quarterly earnings report will be published on Wednesday, May 12th, 2021. Kamada will be holding an earnings conference call on Wednesday, May 12th. Interested parties can register for or listen to the call using this link.

Analyst Opinion on Kamada (NASDAQ:KMDA)

2 Wall Street analysts have issued ratings and price targets for Kamada in the last 12 months. Their average twelve-month price target is $11.00, predicting that the stock has a possible upside of 83.33%. The high price target for KMDA is $11.00 and the low price target for KMDA is $11.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of “Buy.”

Kamada has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $11.00, Kamada has a forecasted upside of 83.3% from its current price of $6.00. Kamada has received no research coverage in the past 90 days.

Dividend Strength: Kamada (NASDAQ:KMDA)

Kamada does not currently pay a dividend. Kamada does not have a long track record of dividend growth.

Insiders buying/selling: Kamada (NASDAQ:KMDA)

In the past three months, Kamada insiders have not sold or bought any company stock. Only 14.25% of the stock of Kamada is held by institutions.

Earnings and Valuation of Kamada (NASDAQ:KMDA

Earnings for Kamada are expected to decrease by -73.81% in the coming year, from $0.42 to $0.11 per share. The P/E ratio of Kamada is 12.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.68. The P/E ratio of Kamada is 12.50, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 42.93. Kamada has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here